Recent Posts on This Topic | See All >
New international study targets rare cancer bringing hope for advanced thymic cancer patientsTags: cancer, clinical trials, scottsdale healthcare, tgen, tgen clinical research services
[Source: TGen] - The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug specifically for thymic cancer based on early promising results at Scottsdale Healthcare.
PHA-848125AC is produced by Nerviano Medical Sciences of Milan, Italy’s largest pharmaceutical research and development facility. It is designed to stop abnormal cell division and duplication, a common feature of cancer.
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.